A Snp Marker of Breast and Ovarian Cancer Risk

The invention provides methods for predicting an increased risk or probability of developing breast or ovarian cancer in a patient based upon the patient's KRAS-Variant and BRCA status.

Attached files:
2010101696.jpg

Patents:
WO 2,010,101,696

Inventor(s): WEIDHAAS JOANNE B [US]

Type of Offer: Sale



Next Patent »
« More Biotech Patents

Share on      


CrowdSell Your Patent